Skip to content

Assessment of clinical efficacy based on musculoskeletal ultrasound for the combined use of Tai Chi and acupuncture therapy in treating knee osteoarthritis of the blood stasis obstructing type.

Assessment of clinical efficacy based on musculoskeletal ultrasound for the combined use of Tai Chi and acupuncture therapy in treating knee osteoarthritis of the blood stasis obstructing type.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001610
Enrollment
Unknown
Registered
2026-06-26
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Stasis Obstruction Type Knee Osteoarthritis

Interventions

Tai Chi+ Acupuncture group :Select acupoints including Dubi (ST35) and Neixiyan on the affected side, and apply short needling therapy combined with the practice of 24-style simplified Tai Chi.
Acupuncture-only group:The acupuncture points are the same as Group A, only using the short needle technique.

Sponsors

Zhenru Town Community Health Service Center of Putuo District in Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for KOA in Western medicine and traditional Chinese medicine; (2) Age between 40 and 75 years; (3) According to the knee joint Kellgren/Lawrence grading criteria, radiographic X-ray grading is I~III; (4) No prior practice of Tai Chi exercise; (5) Disease duration within 10 years, but not during the pain flare-up period, and the patient is conscious, able to understand and complete the questionnaire; (6) Voluntarily participates in this trial and signs the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Skin in the lesion area has ulceration, infection, or other conditions unsuitable for acupuncture treatment; (2) Knee issues caused by other conditions; (3) Severe cardiovascular diseases, severe infections, mental disorders, malignancies, or other serious comorbidities; (4) Received other treatments within the past month, which may affect the evaluation of therapeutic effects; (5) Patients who have undergone knee joint surgery.

Design outcomes

Primary

MeasureTime frame
the Western Ontario and McMaster Osteoarthritis Index;

Secondary

MeasureTime frame
Musculoskeletal ultrasound;

Countries

China

Contacts

Public ContactYan Ying

Zhenru Town Community Health Service Center of Putuo District in Shanghai

408627709@qq.com15921636661

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026